Cambridge Investment Research Advisors
XYL icon

Cambridge Investment Research Advisors’s Xylem XYL Stock Holding History

Cambridge Investment Research Advisors’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.17M Sell
26,799
-5,072
-16% -$585K 0.01% 1338
2026
Q1 		$3.81M Buy
31,871
+1,217
+4% +$160K 0.01% 1126
2025
Q4 		$4.17M Buy
30,654
+85
+0.3% +$12.2K 0.01% 1025
2025
Q3 		$4.51M Buy
30,569
+1,857
+6% +$258K 0.01% 973
2025
Q2 		$3.71M Buy
28,712
+1,497
+6% +$181K 0.01% 1027
2025
Q1 		$3.25M Buy
27,215
+4,429
+19% +$549K 0.01% 1049
2024
Q4 		$2.64M Buy
22,786
+971
+4% +$123K 0.01% 1169
2024
Q3 		$2.95M Sell
21,815
-16,980
-44% -$2.27M 0.01% 1092
2024
Q2 		$5.26M Buy
38,795
+82
+0.2% +$11.2K 0.02% 730
2024
Q1 		$5M Buy
38,713
+20,663
+114% +$2.5M 0.02% 744
2023
Q4 		$2.06M Sell
18,050
-553
-3% -$55.2K 0.01% 1173
2023
Q3 		$1.69M Buy
18,603
+553
+3% +$57K 0.01% 1244
2023
Q2 		$2.03M Buy
18,050
+1,712
+10% +$181K 0.01% 1166
2023
Q1 		$1.71M Buy
16,338
+106
+0.7% +$11.1K 0.01% 1219
2022
Q4 		$1.79M Buy
16,232
+2,506
+18% +$263K 0.01% 1138
2022
Q3 		$1.2M Buy
13,726
+336
+3% +$30.5K 0.01% 1351
2022
Q2 		$1.05M Sell
13,390
-655
-5% -$54.1K 0.01% 1450
2022
Q1 		$1.2M Sell
14,045
-1,252
-8% -$120K 0.01% 1448
2021
Q4 		$1.83M Sell
15,297
-229
-1% -$28.4K 0.01% 1201
2021
Q3 		$1.92M Buy
15,526
+256
+2% +$32.9K 0.01% 1123
2021
Q2 		$1.83M Sell
15,270
-830
-5% -$94.8K 0.01% 1169
2021
Q1 		$1.69M Buy
16,100
+862
+6% +$87.4K 0.01% 1091
2020
Q4 		$1.55M Sell
15,238
-2,377
-13% -$223K 0.01% 1062
2020
Q3 		$1.48M Buy
17,615
+2,789
+19% +$217K 0.01% 964
2020
Q2 		$963K Buy
14,826
+5,356
+57% +$354K 0.01% 1141
2020
Q1 		$617K Buy
9,470
+1,859
+24% +$146K 0.01% 1247
2019
Q4 		$600K Buy
7,611
+913
+14% +$71.1K ﹤0.01% 1466
2019
Q3 		$533K Buy
6,698
+232
+4% +$18.2K ﹤0.01% 1458
2019
Q2 		$541K Buy
6,466
+1,306
+25% +$104K 0.01% 1375
2019
Q1 		$408K Buy
5,160
+102
+2% +$7.44K ﹤0.01% 1613
2018
Q4 		$337K Buy
5,058
+524
+12% +$36.3K ﹤0.01% 1586
2018
Q3 		$362K Buy
4,534
+118
+3% +$8.81K ﹤0.01% 1663
2018
Q2 		$298K Sell
4,416
-2,287
-34% -$166K ﹤0.01% 1737
2018
Q1 		$516K Buy
6,703
+117
+2% +$8.65K 0.01% 1338
2017
Q4 		$449K Buy
6,586
+582
+10% +$38.6K 0.01% 1375
2017
Q3 		$376K Sell
6,004
-160
-3% -$9.56K 0.01% 1415
2017
Q2 		$342K Buy
6,164
+12
+0.2% +$625 0.01% 1433
2017
Q1 		$309K Buy
6,152
+780
+15% +$38K 0.01% 1356
2016
Q4 		$266K Buy
5,372
+143
+3% +$7.25K 0.01% 1348
2016
Q3 		$274K Sell
5,229
-27
-0.5% -$1.32K 0.01% 1359
2016
Q2 		$235K Sell
5,256
-74
-1% -$3.21K 0.01% 1309
2016
Q1 		$218K Buy
+5,330
New +$196K ﹤0.01% 1356

Other funds holding XYL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Cambridge Investment Research Advisors's XYL Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Xylem (XYL) stake by 16% in Q2 2026, selling an estimated $585K and leaving 26,799 shares worth $3.17M. The position accounts for 0.01% of the portfolio, ranked #1338.

Cambridge Investment Research Advisors first reported a position in XYL in Q1 2016 and has held it in 42 quarters since. The position peaked at $5.26M in Q2 2024. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Cambridge Investment Research Advisors held 26,799 shares of Xylem worth $3.17M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 5,072 Xylem shares in Q2 2026, an estimated $585K.
  • Xylem made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1338 holding.
  • Cambridge Investment Research Advisors first reported a position in Xylem in Q1 2016 and has held it in 42 quarters since.
  • Cambridge Investment Research Advisors's Xylem position peaked at $5.26M in Q2 2024.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.